Literature DB >> 11385506

Heme oxygenase-1 protects against vascular constriction and proliferation.

H J Duckers1, M Boehm, A L True, S F Yet, H San, J L Park, R Clinton Webb, M E Lee, G J Nabel, E G Nabel.   

Abstract

Heme oxygenase (HO-1, encoded by Hmox1) is an inducible protein activated in systemic inflammatory conditions by oxidant stress. Vascular injury is characterized by a local reparative process with inflammatory components, indicating a potential protective role for HO-1 in arterial wound repair. Here we report that HO-1 directly reduces vasoconstriction and inhibits cell proliferation during vascular injury. Expression of HO-1 in arteries stimulated vascular relaxation, mediated by guanylate cyclase and cGMP, independent of nitric oxide. The unexpected effects of HO-1 on vascular smooth muscle cell growth were mediated by cell-cycle arrest involving p21Cip1. HO-1 reduced the proliferative response to vascular injury in vivo; expression of HO-1 in pig arteries inhibited lesion formation and Hmox1-/- mice produced hyperplastic arteries compared with controls. Induction of the HO-1 pathway moderates the severity of vascular injury by at least two adaptive mechanisms independent of nitric oxide, and is a potential therapeutic target for diseases of the vasculature.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11385506     DOI: 10.1038/89068

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  136 in total

Review 1.  A critical appraisal of the hemodynamic signal driving liver regeneration.

Authors:  Kerstin Abshagen; Christian Eipel; Brigitte Vollmar
Journal:  Langenbecks Arch Surg       Date:  2012-02-07       Impact factor: 3.445

2.  Bach1-dependent and -independent regulation of heme oxygenase-1 in keratinocytes.

Authors:  Shuko Okada; Akihiko Muto; Eisaku Ogawa; Ayako Nakanome; Yasutake Katoh; Shuntaro Ikawa; Setsuya Aiba; Kazuhiko Igarashi; Ryuhei Okuyama
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

3.  Carbon monoxide and bilirubin from heme oxygenase-1 suppresses reactive oxygen species generation and plasminogen activator inhibitor-1 induction.

Authors:  Hayato Matsumoto; Kazunobu Ishikawa; Hiroyuki Itabe; Yukio Maruyama
Journal:  Mol Cell Biochem       Date:  2006-04-20       Impact factor: 3.396

Review 4.  Novel therapies for cyclic GMP control of vascular smooth muscle growth.

Authors:  David A Tulis
Journal:  Am J Ther       Date:  2008 Nov-Dec       Impact factor: 2.688

Review 5.  HO-1 overexpression and underexpression: Clinical implications.

Authors:  George S Drummond; Jeffrey Baum; Menachem Greenberg; David Lewis; Nader G Abraham
Journal:  Arch Biochem Biophys       Date:  2019-08-16       Impact factor: 4.013

6.  Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression.

Authors:  Jeffrey S Gilbert; Sara A B Gilbert; Marietta Arany; Joey P Granger
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

Review 7.  Antioxidant enzyme gene transfer for ischemic diseases.

Authors:  Jian Wu; James G Hecker; Nipavan Chiamvimonvat
Journal:  Adv Drug Deliv Rev       Date:  2009-02-20       Impact factor: 15.470

8.  Endothelial dysfunction and reduced antioxidant protection in an animal model of the developmental origins of cardiovascular disease.

Authors:  Joanne L Rodford; Christopher Torrens; Richard C M Siow; Giovanni E Mann; Mark A Hanson; Geraldine F Clough
Journal:  J Physiol       Date:  2008-07-31       Impact factor: 5.182

9.  Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse.

Authors:  Matthias H Kapturczak; Clive Wasserfall; Todd Brusko; Martha Campbell-Thompson; Tamir M Ellis; Mark A Atkinson; Anupam Agarwal
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 10.  Heme oxygenase-1 in tumors: is it a false friend?

Authors:  Alicja Jozkowicz; Halina Was; Jozef Dulak
Journal:  Antioxid Redox Signal       Date:  2007-12       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.